These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 19090775

  • 1. Risk factors for early and late transmission of HIV via breast-feeding among infants born to HIV-infected women in a randomized clinical trial in Botswana.
    Shapiro RL, Smeaton L, Lockman S, Thior I, Rossenkhan R, Wester C, Stevens L, Moffat C, Arimi P, Ndase P, Asmelash A, Leidner J, Novitsky V, Makhema J, Essex M.
    J Infect Dis; 2009 Feb 01; 199(3):414-8. PubMed ID: 19090775
    [Abstract] [Full Text] [Related]

  • 2. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, Heymann SJ, Gilbert PB, Stevens L, Peter T, Kim S, van Widenfelt E, Moffat C, Ndase P, Arimi P, Kebaabetswe P, Mazonde P, Makhema J, McIntosh K, Novitsky V, Lee TH, Marlink R, Lagakos S, Essex M, Mashi Study Team.
    JAMA; 2006 Aug 16; 296(7):794-805. PubMed ID: 16905785
    [Abstract] [Full Text] [Related]

  • 3. Interventions for preventing late postnatal mother-to-child transmission of HIV.
    Horvath T, Madi BC, Iuppa IM, Kennedy GE, Rutherford G, Read JS.
    Cochrane Database Syst Rev; 2009 Jan 21; 2009(1):CD006734. PubMed ID: 19160297
    [Abstract] [Full Text] [Related]

  • 4. Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment.
    Shapiro RL, Holland DT, Capparelli E, Lockman S, Thior I, Wester C, Stevens L, Peter T, Essex M, Connor JD, Mirochnick M.
    J Infect Dis; 2005 Sep 01; 192(5):720-7. PubMed ID: 16088821
    [Abstract] [Full Text] [Related]

  • 5. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    Kesho Bora Study Group, de Vincenzi I.
    Lancet Infect Dis; 2011 Mar 01; 11(3):171-80. PubMed ID: 21237718
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
    Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, Kinuthia J, Njiri F, John-Stewart GC.
    Antivir Ther; 2008 Mar 01; 13(6):799-807. PubMed ID: 18839781
    [Abstract] [Full Text] [Related]

  • 8. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.
    Lallemant M, Jourdain G, Le Coeur S, Mary JY, Ngo-Giang-Huong N, Koetsawang S, Kanshana S, McIntosh K, Thaineua V, Perinatal HIV Prevention Trial (Thailand) Investigators.
    N Engl J Med; 2004 Jul 15; 351(3):217-28. PubMed ID: 15247338
    [Abstract] [Full Text] [Related]

  • 9. Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine.
    Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, John-Stewart GC.
    AIDS; 2005 Sep 02; 19(13):1415-22. PubMed ID: 16103773
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission.
    Hudgens MG, Taha TE, Omer SB, Jamieson DJ, Lee H, Mofenson LM, Chasela C, Kourtis AP, Kumwenda N, Ruff A, Bedri A, Jackson JB, Musoke P, Bollinger RC, Gupte N, Thigpen MC, Taylor A, van der Horst C.
    Clin Infect Dis; 2013 Jan 02; 56(1):131-9. PubMed ID: 22997212
    [Abstract] [Full Text] [Related]

  • 13. Independent effects of nevirapine prophylaxis and HIV-1 RNA suppression in breast milk on early perinatal HIV-1 transmission.
    Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, Njiri F, John-Stewart GC.
    J Acquir Immune Defic Syndr; 2007 Dec 01; 46(4):472-8. PubMed ID: 18077838
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana.
    Shapiro RL, Thior I, Gilbert PB, Lockman S, Wester C, Smeaton LM, Stevens L, Heymann SJ, Ndung'u T, Gaseitsiwe S, Novitsky V, Makhema J, Lagakos S, Essex M.
    AIDS; 2006 Jun 12; 20(9):1281-8. PubMed ID: 16816557
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission.
    Lehman DA, Chung MH, John-Stewart GC, Richardson BA, Kiarie J, Kinuthia J, Overbaugh J.
    AIDS; 2008 Jul 31; 22(12):1475-85. PubMed ID: 18614871
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.